Katrina Burgos | July 1, 2014
When it comes to a cancer diagnosis, timing can be everything. An early diagnosis can make a big difference when it comes to treatment possibilities. Pancreatic Ductile Adenocarcinoma (PDAC) has a 5 year survival rate of 6% according to Dr. Reginald Hill, Archibald Assistant Professor of Cancer Biology at the University of Notre Dame. Improving detection rates is a crucial step in changing that statistic.
“The biggest clinical challenges that we face with pancreatic cancer are early detection and chemoresistance. My research focuses on both sides,” Hill said.